Literature DB >> 29184771

Acute myocardial infarction and stroke secondary to valve thrombosis following transcatheter aortic valve replacement-what can happen when antiplatelet agents are stopped.

Mau Chu Lam1, Gajen Kanaganayagam2, Yousif Ahmad2, Michael Fertleman3, Ben Ariff4.   

Abstract

Entities:  

Year:  2017        PMID： 29184771      PMCID： PMC5682404          DOI： 10.21037/qims.2017.10.04

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN： 2223-4306


× No keyword cloud information.
  8 in total

Review 1.  2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.

Authors:  David R Holmes; Michael J Mack; Sanjay Kaul; Arvind Agnihotri; Karen P Alexander; Steven R Bailey; John H Calhoon; Blase A Carabello; Milind Y Desai; Fred H Edwards; Gary S Francis; Timothy J Gardner; A Pieter Kappetein; Jane A Linderbaum; Chirojit Mukherjee; Debabrata Mukherjee; Catherine M Otto; Carlos E Ruiz; Ralph L Sacco; Donnette Smith; James D Thomas
Journal:  J Am Coll Cardiol       Date:  2012-01-31       Impact factor: 24.094

2.  2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Authors:  Catherine M Otto; Dharam J Kumbhani; Karen P Alexander; John H Calhoon; Milind Y Desai; Sanjay Kaul; James C Lee; Carlos E Ruiz; Christina M Vassileva
Journal:  J Am Coll Cardiol       Date:  2017-01-04       Impact factor: 24.094

3.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Authors:  Steen Dalby Kristensen; Juhani Knuuti; Antti Saraste; Stefan Anker; Hans Erik Bøtker; Stefan De Hert; Ian Ford; Jose Ramón Gonzalez-Juanatey; Bulent Gorenek; Guy Robert Heyndrickx; Andreas Hoeft; Kurt Huber; Bernard Iung; Keld Per Kjeldsen; Dan Longrois; Thomas F Lüscher; Luc Pierard; Stuart Pocock; Susanna Price; Marco Roffi; Per Anton Sirnes; Miguel Sousa-Uva; Vasilis Voudris; Christian Funck-Brentano
Journal:  Eur Heart J       Date:  2014-08-01       Impact factor: 29.983

4.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

5.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

Review 6.  Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement.

Authors:  John Webb; Josep Rodés-Cabau; Stephen Fremes; Philippe Pibarot; Marc Ruel; Reda Ibrahim; Robert Welsh; Christopher Feindel; Samuel Lichtenstein
Journal:  Can J Cardiol       Date:  2012-06-15       Impact factor: 5.223

7.  Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study.

Authors:  Tarun Chakravarty; Lars Søndergaard; John Friedman; Ole De Backer; Daniel Berman; Klaus F Kofoed; Hasan Jilaihawi; Takahiro Shiota; Yigal Abramowitz; Troels H Jørgensen; Tanya Rami; Sharjeel Israr; Gregory Fontana; Martina de Knegt; Andreas Fuchs; Patrick Lyden; Alfredo Trento; Deepak L Bhatt; Martin B Leon; Raj R Makkar
Journal:  Lancet       Date:  2017-03-19       Impact factor: 79.321

8.  High risk of thromboemboli early after bioprosthetic cardiac valve replacement.

Authors:  M Heras; J H Chesebro; V Fuster; W J Penny; D E Grill; K R Bailey; G K Danielson; T A Orszulak; J R Pluth; F J Puga
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.